在微血管出血模型中,补充抑制可以在多个层面上降低静血反应
Murielle Golomingi1, Jessie Kohler1, Christina Lamers2
1Experimental Haemostasis Group, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
Frontiers in immunology
|September 29, 2023
概括
补体系统在血液静止中发挥作用,在血管损伤期间影响血块形成和血小板激活. 抑制补充通路显著影响这些过程,表明治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 血栓形成的原因之一是血栓形成.
背景情况:
- 静血,止血的过程,涉及血小板塞的形成和纤维素网状稳定通过凝血级联.
- 补体和凝血系统之间的相互作用可以加剧疾病中的血栓炎症.
- 补充剂在血管损伤后生理血液静止中的确切作用尚不清楚.
研究的目的:
- 调查补充成分和激活在机械血管损伤的静血反应中的作用.
- 探索各种补充抑制剂对凝块形成和血小板激活的影响.
主要方法:
- 使用了微血管出血模型与人体内皮细胞和全血.
- 引入机械伤害以模拟船舶损坏.
- 管理的补充抑制剂向莱克丁 (MASP-1,MASP-2),经典 (C1s),替代 (FD) 和常见 (C3,C5) 途径,以及三重抑制剂 (TriFu).
- 使用共聚焦显微镜实时量化纤维素沉积和血小板激活标记物 (CD62P).
主要成果:
- 抑制MASP-2或C1s的药物对纤维素形成没有显著影响.
- 替代途径抑制 (FD) 显著降低了血小板激活.
- 常见途径抑制剂 (C3,C5) 大大降低了纤维素的形成,C3抑制也降低了血小板激活.
- 三重抑制 (TriFu) 降低了纤维素形成和血小板激活.
- TriFu,MASP-1和C3抑制剂对凝块形成表现出最强烈的影响.
结论:
- 补充系统的激活通过影响纤维素凝块形成和血小板激活来影响血静.
- 针对不同补充通路的调节器对血液静止有不同的影响.
- 补充-凝血相互作用可能已经演变为帮助血液静止,但可以促进病态状态中的血栓形成.
相关概念视频
Introduction to Hemostasis
8.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.2K
Extrinsic and Intrinsic Pathways of Hemostasis
8.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
Disorders of Hemostasis
982
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
982
Formation of the Platelet Plug
6.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.6K
Clot Retraction and Fibrinolysis
6.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.4K


